Drug reference
migalastat
Oral chaperone therapy
Oral chaperone therapy
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Stabilizes mutant forms of alpha-galactosidase, increasing its enzymatic activity.
Indications
Fabry's disease (specifically for patients with variants amenable to this therapy)
Drug interactions
1 additional unreviewed or low-confidence interaction hidden because their provenance or source detail is insufficient.
Related guidelines
Ask House about migalastat
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10